Aug 2026· International Journal of Reproduction Contraception Obstetrics and Gynecology· Vol 15, pp. 3465-3470· 0 citations· 20 references
TL;DR
Dealing with PMOS is challenging since normal pubertal development overlaps typical features of syndrome, and healthcare providers should make the diagnosis of PMOS on evidence-based guidelines to prevent delayed, under diagnosis or over diagnosis.
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder. Recently its name has been changed as polyendocrine metabolic ovarian syndrome (PMOS), However, the term PCOS is inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, delayed diagnosis, fragmented care, and stigma. So, in this study PMOS term will be used instead of PCOS but references will be used for PCOS term because newer studies are less with new terms. PMOS is characterized by hyperandrogenism, ovulatory dysfunction, and ovarian morphology.
Methods: A retrospective observation study conducted at R. K. Hospital Indore over period of two years. Total 100 adolescents aged between 12 and 19 years, who were presenting with symptoms such as menstrual irregularities, acne, hirsutism, weight gain were screened. A questionnaire was distributed. Menstrual irregularity was seen in 85%, acne in 72%, hirsutism in 56% and weight gain in 50%. Life style modifications recommended to all include daily counselling, less sedentary behavior, exercise, proper sleep and reduce screen time.
Results: Following healthy lifestyle, menstrual irregularities reduced and most of patients improved with Acne, hirsutism and weight reduction.
Conclusions: Diagnosing PMOS is challenging since normal pubertal development overlaps typical features of syndrome. Healthcare providers should make the diagnosis of PMOS on evidence-based guidelines to prevent delayed, under diagnosis or over diagnosis. Psychological care, dietary care, lifestyle modifications are key steps. Support could significantly affect adolescent’s motivation and amp; ability to change their behaviours.
Recognizing PMOS as an early-life marker of cardiometabolic disease highlights opportunities for earlier diagnosis, prevention, and individualized risk stratification, supporting integrated, patient-centered care across the life course.
M. Forslund, J. Melin, A. Joham et al.· Journal of Internal Medicine· 0 citations
Background: PMOS is most common hormonal disorder in females of reproductive age group. In PMOS many pearl sized cysts are formed in the ovaries. These cysts contain immature eggs. High LH, low FSH, high Testosterone in PMOS causes changes in physical appearance, irregularity in menstrual cycle and if not treated in ti...
Vani Bansal, Palak Meena, Kunal Bansal et al.· International Journal of Res...· 0 citations
A case of a 20 year-old female with a 2-year history of irregular menses and an obesity issue and a proper, customized ayurvedic treatment for PMOS, which showed normalization in ovarian size and no signs of peripheral follicles, indicating an improvement in PMOS.
Rukhsar, Meeta Jhala, Muskan Jain· Journal of Ayurveda and Inte...· 0 citations
Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine and metabolic disorders among women of reproductive age worldwide, with an estimated global prevalence of 8-13% depending on the diagnostic criteria used. The term Polycystic Ovary Syndrome is a common clinical finding, but has been increasingly criti...
Mahi Killekar· International Journal of Adv...· 0 citations
The findings emphasise the need for routine metabolic and endocrine evaluation in women with PCOS to facilitate early identification of associated abnormalities and guide timely clinical management.
P. Kokate, Harshali Walmik Shirsath, Manoj Naphde et al.· National Journal of Laborato...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.